Budget Impact Analysis of Nanoliposomal Irinotecan for Treatment of Pancreatic Cancer Following Progression on Gemcitabine - A Us Payer Perspective
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2131
https://www.valueinhealthjournal.com/article/S1098-3015(16)33497-0/fulltext
Title :
Budget Impact Analysis of Nanoliposomal Irinotecan for Treatment of Pancreatic Cancer Following Progression on Gemcitabine - A Us Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33497-0&doi=10.1016/j.jval.2016.09.2131
First page :
A718
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2016